← Back to headlines
Pfizer, Valneva Report Strong Efficacy Data from Lyme Vaccine Trial
Pfizer and Valneva have reported strong efficacy data from their joint Lyme vaccine trial, indicating positive progress in its development.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
